Record NNP B-NP O
date NN I-NP O
: : O O
2064-06-16 CD O B-DATE
EDUCARE-FARGO NNP B-NP B-HOSPITAL
INPATIENT NNP I-NP O
DIALYSIS NNP I-NP O
FELLOW NNP I-NP O
NOTE NNP I-NP O
Outpatient JJ B-NP O
Nephrologist NNP I-NP O
: : O O
unknown NN B-NP O
Outpatient NN B-NP O
Dialysis NNP I-NP O
Unit NNP I-NP O
: : O O
CMH WDT O B-HOSPITAL
Dialysis NNP B-NP O
access NN I-NP O
: : O O
L NNP B-NP O
AVG NNP I-NP O
Reason NN B-NP O
for IN B-PP O
admission NN B-NP O
: : O O
N/V NNP B-NP O
, , O O
abdo NN B-NP O
pain NN I-NP O
HPI NNP B-NP O
: : O O
Pt NNP B-NP O
is VBZ B-VP O
Spanish-speaking JJ B-ADJP O
only RB B-ADVP O
- : O O
Hx NN B-NP O
from IN B-PP O
patient NN B-NP O
and CC I-NP O
chart NN I-NP O
. . O O
44 CD B-NP B-AGE
M NNP I-NP O
ESRD NNP I-NP O
on IN B-PP O
HD NNP B-NP O
presumed VBD B-VP O
2/2 CD B-NP O
Type NN I-NP O
1 CD I-NP O
DM NNP I-NP O
with IN B-PP O
nausea/vomiting NN B-NP O
since IN B-PP O
Wednesday NNP B-NP B-DATE
( -LRB- I-NP O
2d JJ I-NP O
ago IN B-PP O
) -RRB- B-NP O
. . O O
No DT B-NP O
CP/SOB NNP I-NP O
, , O O
no DT B-NP O
sick JJ I-NP O
contacts NNS I-NP O
( -LRB- I-NP O
lives NNS I-NP O
with IN B-PP O
mother NN B-NP O
) -RRB- I-NP O
. . O O
Has NNP B-NP O
felt VBD B-VP O
"warm" RB B-ADVP O
, , O O
but CC O O
did VBD B-VP O
not RB I-VP O
take VB I-VP O
temperature NN B-NP O
at IN B-PP O
home NN B-NP O
. . O O
Last JJ O O
ate VBD B-VP O
at IN B-PP O
breakfast NN B-NP O
Thursday NNP B-NP B-DATE
morning NN I-NP O
(yesterday NN I-NP O
) -RRB- I-NP O
. . O O
No DT B-NP O
abdo NN I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
diarrhea NN I-NP O
. . O O
Came VBD B-VP O
to TO B-PP O
ED NNP B-NP O
last JJ B-NP O
night NN I-NP O
, , O O
afebrile JJ B-ADVP O
- : O O
given VBN B-NP O
morphine NN I-NP O
2mg VBZ B-VP O
IV NNP B-NP O
x NN I-NP O
1 CD I-NP O
for IN B-PP O
2/10 CD B-NP O
abdo NN I-NP O
pain NN I-NP O
and CC O O
now RB B-VP O
says VBZ I-VP O
pain NN B-NP O
++improved VBN B-VP O
. . B-NP O
Also RB B-VP O
noted VBN I-VP O
to TO I-VP O
be VB I-VP O
hypertensive JJ B-NP O
( -LRB- I-NP O
190/100 CD I-NP O
) -RRB- I-NP O
and CC I-NP O
Rx NNP I-NP O
with IN B-PP O
his PRP$ B-NP O
usual JJ I-NP O
po NN I-NP O
meds NNS I-NP O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
hydralazine NN B-NP O
10mg CD I-NP O
IV NNP I-NP O
x NN I-NP O
1 CD B-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
also RB I-VP O
received VBN I-VP O
Kayexalate NNP B-NP O
30g CD I-NP O
x NN I-NP O
1 CD I-NP O
in IN B-PP O
the DT B-NP O
ED NNP I-NP O
for IN B-PP O
K NNP B-NP O
6.0. . I-NP O
Chronic NNP I-NP O
dysuria FW I-NP O
- : O O
still RB B-ADVP O
makes VBZ B-VP O
significant JJ B-NP O
urine NN I-NP O
. . O O
Has VBZ B-VP O
been VBN I-VP O
compliant JJ B-ADJP O
with IN B-PP O
dialysis NN B-NP O
sessions NNS I-NP O
, , O O
last JJ B-NP O
dialysis NN I-NP O
Tuesday NNP B-NP B-DATE
. . I-NP O
ROS NNP I-NP O
otherwise RB I-NP O
negative JJ I-NP O
. . O O
Past NNP B-NP O
Medical NNP I-NP O
History NNP I-NP O
: : O O
ESRD NNP B-NP O
on IN B-PP O
HD NNP B-NP O
x NN I-NP O
2yrs . O O
- : B-NP O
L NNP I-NP O
AVG NNP I-NP O
placed VBD B-VP O
2 CD B-NP O
yrs NNS I-NP O
ago RB B-ADVP O
, , O O
previously RB B-ADVP O
dialyzed VBD B-VP O
via IN B-PP O
tunneled VBN B-NP O
catheter NN I-NP O
Type NNP B-NP O
1 CD I-NP O
DM NNP I-NP O
since IN B-PP O
age NN B-NP O
25 CD I-NP B-AGE
- : O O
+legally RB B-ADJP O
blind JJ I-ADJP O
, , O O
PVD NNP B-NP O
, , O O
nephropathy NN B-NP O
bilateral JJ B-NP O
TMA NNP I-NP O
- : O O
healing NN B-VP O
ulcer NN B-NP O
on IN B-PP O
R NN B-NP O
Allergies NNP B-NP O
: : O O
NKDA NNP O O
Medications NNS B-NP O
( -LRB- B-VP O
as IN B-PP O
per IN B-PP O
his PRP$ B-NP O
clinic NN I-NP O
visit VB B-VP O
06/11/64 CD B-NP B-DATE
- : O O
needs VBZ B-VP O
to TO I-VP O
be VB I-VP O
clarified VBN I-VP O
) -RRB- B-ADVP O
: : O O
PhosLo NNP B-NP O
667 CD I-NP O
mg NN I-NP O
b.i.d. VBN B-VP O
, , O O
omeprazole JJ B-NP O
20 CD I-NP O
mg JJ B-ADJP O
daily JJ B-ADVP O
, , O O
Zelnorm NNP B-NP O
6 CD I-NP O
mg NN I-NP O
b.i.d. NN I-NP O
, , O O
metoclopramide NN B-NP O
10 CD I-NP O
mg NN I-NP O
t.i.d. VBN B-VP O
, , O O
Lopid NNP B-NP O
600 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
, , I-NP O
lisinopril JJ I-NP O
20 CD I-NP O
mg NN I-NP O
M NNP I-NP B-DATE
W NNP I-NP B-DATE
F NNP I-NP B-DATE
S NNP I-NP B-DATE
, , O O
lactulose JJ B-NP O
two CD I-NP O
teaspoonfuls NNS I-NP O
b.i.d. VBN B-VP O
, , O O
Humulin NNP B-NP O
70/35 CD I-NP O
units NNS I-NP O
daily RB B-ADVP O
, , O O
and CC O O
enalapril VB B-VP O
10 CD B-NP O
mg NN I-NP O
on IN B-PP O
Thursdays NNS B-NP B-DATE
and CC I-NP O
Sundays NNS I-NP B-DATE
, , O O
losartan NN B-NP O
50 CD I-NP O
mg NN I-NP O
, , O O
citalopram NN B-NP O
40 CD I-NP O
mg NN I-NP O
and CC O O
atropine JJ B-NP O
eye NN I-NP O
drops VBZ B-VP O
in IN B-PP O
the DT B-NP O
left JJ I-NP O
eye NN I-NP O
t.i.d NN I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
uses VBZ B-VP O
prednisolone NN B-NP O
eyedrops NNS I-NP O
daily RB B-ADVP O
. . O O
Social NNP B-NP O
History NNP I-NP O
: : O O
No DT B-NP O
cigarette NN I-NP O
or CC I-NP O
illicit JJ I-NP O
drug NN I-NP O
use NN I-NP O
. . O O
Previous JJ B-NP O
heavy JJ I-NP O
EtOH NNP I-NP O
use NN I-NP O
, , O O
though IN B-SBAR O
none NN B-NP O
now RB B-ADVP O
. . B-VP O
Lives NNS B-NP O
with IN B-PP O
his PRP$ B-NP O
mother NN I-NP O
who WP B-NP O
is VBZ B-VP O
also RB B-ADVP O
diabetic JJ B-ADJP O
and CC O O
also RB B-ADJP O
blind JJ I-ADJP O
. . O O
Visiting NN B-NP O
nurses NNS I-NP O
are VBP B-VP O
coming VBG I-VP O
to TO B-PP O
the DT B-NP O
home NN I-NP O
according VBG B-VP O
to TO B-PP O
the DT B-NP O
patient NN I-NP O
twice RB B-ADVP O
per IN B-PP O
week NN B-NP O
and CC O O
there EX B-NP O
is VBZ B-VP O
also RB B-ADVP O
a DT B-NP O
health NN I-NP O
care NN I-NP O
worker NN I-NP O
who WP B-NP O
comes VBZ B-VP O
to TO I-VP O
help VB I-VP O
with IN B-PP O
bathing NN B-NP O
three CD I-NP O
times NNS I-NP O
per IN B-PP O
week NN B-NP O
. . O O
Originally RB B-ADVP O
from IN B-PP O
Panama NNP B-NP B-COUNTRY
, , O O
grew VBD B-VP O
up RP B-PRT O
in IN B-PP O
Peru NNP B-NP B-COUNTRY
, , O O
and CC O O
came VBD B-VP O
to TO B-PP O
the DT B-NP O
US NNP I-NP B-COUNTRY
at IN B-PP O
age NN B-NP O
11 CD I-NP B-AGE
. . O O
Former NNP B-NP O
Editor NNP I-NP B-PROFESSION
. . O O
PHYSICAL NNP B-NP O
EXAM NNPS I-NP O
Temp NNP B-NP O
: : O O
96 CD O O
BP NNP B-NP O
: : O O
130/71 CD O O
HR NNP B-NP O
: : O O
92 CD O O
97 CD B-NP O
%RA NN I-NP O
Gen NNP B-NP O
: : O O
Chronically-unwell NNP B-NP O
appearing VBG I-NP O
man NN I-NP O
, , O O
but CC O O
in IN B-PP O
NAD. NNP B-NP O
HEENT NNP B-NP O
: : O O
sclerae NNS B-NP O
non-icteric JJ B-ADVP O
, , O O
O&P RB B-ADVP O
clear JJ B-ADJP O
and CC I-ADJP O
moist JJ I-ADJP O
, , O O
missing VBG B-VP O
teeth NNS B-NP O
Neck NNP B-NP O
: : O O
supple NN B-NP O
, , O O
no DT B-NP O
LAD NN I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
Lungs NNP B-NP O
: : O O
CTA NNP B-NP O
b/l CC O O
Cor NNP B-NP O
: : O O
regular JJ B-NP O
, , I-NP O
s1s2 NN I-NP O
, , O O
no DT B-NP O
m/c/r/g NN I-NP O
Abd NNP B-NP O
: : B-VP O
soft JJ B-ADJP O
, , O O
NTND NNP B-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
, , O O
no DT B-NP O
abdominal NN I-NP O
bruits NNS I-NP O
Ext JJ B-NP O
: : O O
no DT B-NP O
edema NN I-NP O
in IN B-PP O
LE JJ B-NP O
b/l NN I-NP O
, , O O
bilateral JJ B-NP O
TMA NN I-NP O
Skin NNP B-NP O
: : O O
warm JJ B-NP O
, , I-NP O
smooth JJ I-NP O
, , O O
no DT B-NP O
rashes NNS I-NP O
Back RB B-ADVP O
: : O O
no NN B-NP O
CVAT NN I-NP O
Vascular JJ B-NP O
access NN I-NP O
: : O O
site NN B-NP O
clean JJ I-NP O
and CC O O
without IN B-PP O
inflammation NN B-NP O
, , I-NP O
systolic JJ I-NP O
and CC I-NP O
diastolic JJ I-NP O
bruit NN I-NP O
present NN I-NP O
LABS NNP B-NP O
: : O O
Date/Time NNP B-NP O
NA NNP I-NP O
K NNP I-NP O
CL NN I-NP O
CO2 . O O
06/16/2064 CD B-NP B-DATE
137 CD I-NP O
6.0 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
104 CD B-NP O
23 CD I-NP O
Date/Time NNP B-NP O
BUN NNP I-NP O
CRE NNP I-NP O
EGFR NNP I-NP O
GLU . O O
06/16/2064 CD B-NP B-DATE
58 CD I-NP O
( -LRB- I-NP O
*# NN I-NP O
) -RRB- I-NP O
7.1 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
9 CD I-NP O
[1 CD I-NP O
] NN I-NP O
108 CD O O
Date/Time NNP B-NP O
ANION NN I-NP O
06/16/2064 CD B-NP B-DATE
10 CD I-NP O
Date/Time NNP B-NP O
CA NNP I-NP O
TBILI NNP I-NP O
TP NNP I-NP O
ALB NNP I-NP O
06/16/2064 CD B-NP B-DATE
10.5 CD I-NP O
0.5 CD I-NP O
8.3 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
4.4 CD O O
Date/Time NNP B-NP O
GLOB NNP I-NP O
06/16/2064 CD B-NP B-DATE
3.9 CD I-NP O
Date/Time NNP B-NP O
ALT/SGPT NNP I-NP O
AST/SGOT NNP I-NP O
ALKP NNP I-NP O
TBILI . O O
06/16/2064 CD B-NP B-DATE
32 CD I-NP O
21 CD I-NP O
155 CD I-NP O
( -LRB- O O
* NN B-NP O
) -RRB- I-NP O
0.5 CD O O
Date/Time NNP B-NP O
CK NNP I-NP O
CK-MB NNP I-NP O
TROP-I . O O
06/16/2064 CD B-NP B-DATE
137 CD I-NP O
2.9 CD I-NP O
<assay NN I-NP O
Date/Time NNP B-NP O
WBC NNP I-NP O
HGB NNP I-NP O
HCT NNP I-NP O
MCV NNP I-NP O
06/16/2064 CD B-NP B-DATE
6.21 CD I-NP O
14.7 CD I-NP O
43.3 CD I-NP O
93.3 CD I-NP O
( -LRB- B-PP O
# # B-NP O
) -RRB- O O
Date/Time NNP B-NP O
PLT NNP I-NP O
06/16/2064 CD B-NP B-DATE
226 CD I-NP O
Date/Time NNP B-NP O
PT NNP I-NP O
PT-INR NNP I-NP O
PTT NNP I-NP O
06/16/2064 CD B-NP B-DATE
13.9 CD I-NP O
1.1 CD I-NP O
32.2 CD O O
Date/Time NNP B-NP O
UA-GLUC NNP I-NP O
UA-KET NNP I-NP O
UA-SPGR NNP I-NP O
UA-BLD NNP I-NP O
06/16/2064 CD B-NP B-DATE
TR NNP I-NP O
NEG NNP I-NP O
1.016 CD I-NP O
1+ . O O
Date/Time NNP B-NP O
UA-PH NNP I-NP O
UA-PROT NNP I-NP O
UA-NIT NNP I-NP O
UA-WBC . O O
06/16/2064 CD B-NP B-DATE
8.0 CD I-NP O
3+ JJ I-NP O
NEG NNP I-NP O
NEG NNP I-NP O
ECG NNP B-NP O
: : O O
NSR NNP B-NP O
, , O O
nil JJ B-NP O
acute JJ I-NP O
, , I-NP O
unchanged JJ I-NP O
from IN B-PP O
previous JJ B-NP O
05/05/64 CD I-NP B-DATE
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
: : O O
44 CD B-NP B-AGE
M NNP I-NP O
with IN B-PP O
ESRD NNP B-NP O
on IN B-PP O
HD NNP B-NP O
presents NNS I-NP O
with IN B-PP O
N/V NNP B-NP O
. . O O
His PRP$ B-NP O
symptoms NNS I-NP O
appear VBP B-VP O
to TO I-VP O
be VB I-VP O
resolving VBG I-VP O
and CC O O
this DT B-NP O
may MD B-VP O
represent VB I-VP O
a DT B-NP O
viral JJ I-NP O
gastroenteritis NN I-NP O
, , O O
as IN B-PP O
his PRP$ B-NP O
cardiac NN I-NP O
enzymes NNS I-NP O
are VBP B-VP O
negative JJ B-ADJP O
and CC O O
sugars NNS B-NP O
have VBP B-VP O
been VBN I-VP O
well-controlled JJ B-ADJP O
since IN B-PP O
presentation NN B-NP O
to TO B-PP O
ED. NNP B-NP O
He PRP B-NP O
may MD B-VP O
have VB I-VP O
an DT B-NP O
element NN I-NP O
of IN B-PP O
diabetic JJ B-NP O
gastroparesis NN I-NP O
given VBN B-VP O
his PRP$ B-NP O
medication NN I-NP O
list NN I-NP O
. . O O
We PRP B-NP O
will MD B-VP O
add VB I-VP O
amylase NN B-NP O
and CC I-NP O
lipase NN I-NP O
to TO B-PP O
his PRP$ B-NP O
bloodwork NN I-NP O
to TO B-VP O
r/o VB I-VP O
pancreatitis NN B-NP O
. . O O
Consider VB B-VP O
AXR CC I-VP O
to TO I-VP O
r/o VB I-VP O
constipation NN B-NP O
( -LRB- I-NP O
normally RB B-ADVP O
on IN B-PP O
lactulose NN B-NP O
) -RRB- I-NP O
. . O O
Plan NNP B-NP O
: : O O
1 CD B-NP O
. . I-NP O
HD NNP I-NP O
today NN I-NP O
as IN B-PP O
per IN B-PP O
usual JJ B-NP O
schedule NN I-NP O
and CC I-NP O
prescription NN I-NP O
. . O O
Hold VB B-VP O
Epo RB I-VP O
given VBN I-VP O
Hct NNP B-NP O
elevated VBD B-VP O
. . O O
2. POS B-NP O
Will MD B-VP O
draw VB I-VP O
blood NN B-NP O
Cx IN B-PP O
x NN B-NP O
2 CD I-NP O
, , O O
iron NN B-NP O
studies NNS I-NP O
, , O O
25OH CC O O
Vitamin NNP B-NP O
D NNP I-NP O
, , O O
PTH NNP B-NP O
in IN B-LST O
HD. NNP O O
3. DT B-NP O
Start NNP I-NP O
Nephrocaps NNP I-NP O
. . O O
4 CD B-LST O
. . O O
CAD NNP B-NP O
risk NN I-NP O
: : O O
Start VB B-VP O
ASA NNP B-NP O
81mg CD I-NP O
qd NN I-NP O
. . O O
5 CD B-NP O
. . O O
Polypharmacy NNP B-NP O
: : O O
On IN B-PP O
multiple JJ B-NP O
antihypertensives NNS I-NP O
at IN B-PP O
different JJ B-NP O
doses NNS I-NP O
. . O O
Would MD O O
d/c IN B-PP O
enalapril NN B-NP O
and CC I-NP O
losartan NN I-NP O
. . O O
Use VB B-VP O
only RB B-ADVP O
lisinopril JJ B-NP O
daily RB B-ADVP O
(titrate VBP B-VP O
up RP B-PRT O
as IN B-SBAR O
needed VBN B-NP O
) -RRB- I-NP O
, , O O
but CC O O
ask VB B-VP O
patient NN B-NP O
to TO B-VP O
take VB I-VP O
meds NNS B-NP O
after IN B-PP O
dialysis NN B-NP O
on IN B-PP O
dialysis NN B-NP O
days NNS I-NP O
. . O O
6 CD B-NP O
. . O O
Social NNP B-NP O
work VBP B-VP O
to TO I-VP O
see VB I-VP O
( -LRB- B-NP O
already RB I-NP O
informed VBN I-NP O
) -RRB- I-NP O
. . O O
Nicole NNP B-NP B-DOCTOR
Ostrowski NNP I-NP I-DOCTOR
Renal NNP B-NP O
Fellow NNP I-NP O
56986 CD O B-PHONE
